Related Experiment Video
Updated: May 30, 2026

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
Published on: January 18, 2018
Advances in revascularization for acute ischemic stroke treatment: an update
Muneer Eesa1, Hermann Christian Schumacher, Randall T Higashida
1Neurointerventional Radiology, New York Presbyterian Hospital, College of Physicians & Surgeons, Columbia University, NY, USA.
Newer treatments for acute ischemic stroke, including advanced thrombolytic drugs and endovascular techniques, aim to improve recanalization rates and patient outcomes beyond standard intravenous thrombolysis.
Area of Science:
- Neurology
- Cardiovascular Medicine
- Biomedical Engineering
Background:
- Intravenous thrombolysis with recombinant tissue plasminogen activator (rt-PA) is standard acute ischemic stroke treatment within 4.5 hours.
- However, rt-PA is often ineffective for proximal occlusions and large thrombus burdens, with limited recanalization rates.
Purpose of the Study:
- To review advancements in acute ischemic stroke treatment beyond established intravenous thrombolysis.
- To explore novel thrombolytic agents and endovascular revascularization techniques.
Main Methods:
- Review of current and emerging pharmacological thrombolytic agents (reteplase, tenecteplase, desmoteplase, direct fibrinolytics).
- Analysis of evolving endovascular revascularization strategies, including mechanical clot disruption/extraction and combination therapies.
- Evaluation of safety and efficacy data from ongoing clinical trials for new devices and techniques.
Main Results:
- Newer thrombolytic agents offer pharmacokinetic and hemodynamic advantages.
- Endovascular devices show promise in improving clot removal and recanalization.
- Combination therapies like bridging therapy are being investigated to enhance efficacy.
Conclusions:
- Ongoing innovation in endovascular technology and pharmacological agents is crucial for improving acute ischemic stroke treatment.
- Refined techniques and combination therapies are expected to increase technical success, improve efficacy, and reduce time to recanalization.
- Future treatments aim for better outcomes with minimal procedure-related morbidity.
Related Concept Videos
Ischemic Stroke ll: Pathophysiology
Ischemic Stroke l: Introduction
Acute Coronary Syndrome IV: Interprofessional Care
Peripheral Artery Disease III: Interprofessional Care
Venous Thrombosis III: Interprofessional Care
Coronary Artery Disease V: Interprofessional Care
